Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 459.20
-4.60 (-0.99%)
Nov 11, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $617.60. The average 1-year stock price forecast is 34.49% higher than the current stock price, while the lowest is $520.00 (+13.24%) and the highest is $765.30 (+66.66%).
Price Target: $617.60 (+34.49%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 16 | 17 | 17 | 17 |
| Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 19 | 20 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $526.00 | Buy | Maintains | $526.00 | +14.55% | Nov 3, 2026 |
| DBS | DBS | Buy Initiates $569.90 | Buy | Initiates | $569.90 | +24.11% | Oct 29, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Buy Maintains $620.00 → $625.00 | Buy | Maintains | $620.00 → $625.00 | +36.11% | Oct 29, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $642.29 | Buy | Maintains | $642.29 | +39.87% | Oct 28, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $630.00 | Buy | Maintains | $630.00 | +37.20% | Oct 28, 2026 |
Financial Forecast
Revenue This Year
2.54B
from 2.06B
Increased by 23.58%
Revenue Next Year
4.42B
from 2.54B
Increased by 73.82%
EPS This Year
0.69
from -0.89
EPS Next Year
2.78
from 0.69
Increased by 304.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.